Preeclampsia and Circulating Biomarkers
|ClinicalTrials.gov Identifier: NCT02136667|
Recruitment Status : Unknown
Verified May 2014 by University of Aarhus.
Recruitment status was: Recruiting
First Posted : May 13, 2014
Last Update Posted : January 6, 2015
In order to assess circulating biomarkers of cardiovascular risk, we will conduct a 10-year follow-up study comparing 32 exposed (women with a history of pregnancy complicated by preeclampsia) and 32 unexposed (women with a history of uncomplicated pregnancy).
Participants will be recruited from a well-characterised cohort, previously assembled during their pregnancies, at the Department of Obstetrics at Randers Regional Hospital in 2001-2004.
Blood and urine samples, collected during their pregnancies, are stored in a biobank, thus rendering the possibility of longitudinal assessment.
|Condition or disease|
|Postpartum CVD Risk in Women With Previous Preeclampsia.|
|Study Type :||Observational|
|Estimated Enrollment :||64 participants|
|Study Start Date :||April 2014|
|Primary Completion Date :||December 2014|
|Estimated Study Completion Date :||December 2015|
Women with a history of preeclampsia 10 years ago
Women with a history of uncomplicated pregnancy 10 years ago
- Circulating biomarkers of cardiovascular disease 10 years postpartum. [ Time Frame: 10 years postpartum ]
- Markers of arteriosclerosis and atherosclerosis [ Time Frame: 10 years postpartum ]
- Circulating biomarkers of cardiovascular disease at baseline pregnancy. [ Time Frame: During pregnancy ]
Biospecimen Retention: Samples With DNA
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02136667
|Randers Regional Hospital||Recruiting|
|Randers, Randers NØ, Denmark, 8930|
|Contact: Martin Christensen, MD 004578422354 firstname.lastname@example.org|
|Principal Investigator: Martin Christensen, MD|
|Study Chair:||Ulla B Knudsen, Professor||Department of Obstetrics and Gynaecology, Aarhus University Hospital|
|Principal Investigator:||Martin Christensen, MD||Clinical Research Unit, Randers Regional Hospital|
|Study Director:||Camilla S Kronborg, MD, PhD||Department of Oncology, Aarhus University Hospital|